AllianceBernstein
ORIC icon

AllianceBernstein’s Oric Pharmaceuticals ORIC Stock Holding History

AllianceBernstein’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522K Hold
63,810
– – ﹤0.01% 2616
2025
Q4 		$522K Hold
63,810
– – ﹤0.01% 2641
2025
Q3 		$766K Hold
63,810
– – ﹤0.01% 2467
2025
Q2 		$648K Sell
63,810
-43,622
-41% -$293K ﹤0.01% 2502
2025
Q1 		$599K Buy
107,432
+53,562
+99% +$468K ﹤0.01% 2480
2024
Q4 		$435K Sell
53,870
-8,000
-13% -$73.4K ﹤0.01% 2701
2024
Q3 		$634K Buy
61,870
+17,820
+40% +$176K ﹤0.01% 2552
2024
Q2 		$311K Buy
44,050
+13,890
+46% +$124K ﹤0.01% 2902
2024
Q1 		$415K Buy
30,160
+14,840
+97% +$176K ﹤0.01% 2665
2023
Q4 		$141K Buy
+15,320
New +$111K ﹤0.01% 3024
2022
Q2 		– Sell
-33,100
Closed -$177K – 3342
2022
Q1 		$177K Buy
33,100
+100
+0.3% +$901 ﹤0.01% 3015
2021
Q4 		$485K Buy
33,000
+4,700
+17% +$73.3K ﹤0.01% 2759
2021
Q3 		$592K Hold
28,300
– – ﹤0.01% 2697
2021
Q2 		$501K Buy
28,300
+2,400
+9% +$52.6K ﹤0.01% 2810
2021
Q1 		$635K Buy
25,900
+1,100
+4% +$34.8K ﹤0.01% 2583
2020
Q4 		$839K Buy
24,800
+13,400
+118% +$384K ﹤0.01% 2373
2020
Q3 		$285K Buy
11,400
+1,200
+12% +$28.6K ﹤0.01% 2838
2020
Q2 		$344K Buy
+10,200
New +$326K ﹤0.01% 2820

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AllianceBernstein's ORIC Position: Q1 2026 in Review

AllianceBernstein held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 63,810 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

AllianceBernstein first reported a position in ORIC in Q2 2020 and has held it in 18 quarters since. The position peaked at $839K in Q4 2020. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • AllianceBernstein held 63,810 shares of Oric Pharmaceuticals worth $522K as of Q1 2026.
  • AllianceBernstein left its Oric Pharmaceuticals share count unchanged in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2616 holding.
  • AllianceBernstein first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • AllianceBernstein's Oric Pharmaceuticals position peaked at $839K in Q4 2020.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.